GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 77 filers reported holding GLYCOMIMETICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -98.9% | 320 | -98.9% | 0.00% | – |
| Q1 2021 | $87,000 | -20.2% | 28,900 | 0.0% | 0.00% | – |
| Q4 2020 | $109,000 | +22.5% | 28,900 | 0.0% | 0.00% | – |
| Q3 2020 | $89,000 | -18.3% | 28,900 | 0.0% | 0.00% | – |
| Q2 2020 | $109,000 | +65.2% | 28,900 | 0.0% | 0.00% | – |
| Q1 2020 | $66,000 | -56.9% | 28,900 | 0.0% | 0.00% | – |
| Q4 2019 | $153,000 | +22.4% | 28,900 | 0.0% | 0.00% | – |
| Q3 2019 | $125,000 | -63.7% | 28,900 | 0.0% | 0.00% | – |
| Q2 2019 | $344,000 | -26.0% | 28,900 | -22.5% | 0.00% | -100.0% |
| Q1 2019 | $465,000 | +31.7% | 37,300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $353,000 | -34.3% | 37,300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $537,000 | -10.8% | 37,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $602,000 | +1128.6% | 37,300 | +315.6% | 0.00% | – |
| Q1 2017 | $49,000 | -10.9% | 8,975 | +0.0% | 0.00% | – |
| Q4 2016 | $55,000 | -14.1% | 8,974 | 0.0% | 0.00% | – |
| Q3 2016 | $64,000 | -37.9% | 8,974 | -36.8% | 0.00% | – |
| Q2 2016 | $103,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,000,000 | $4,500,000 | 0.69% |
| Artal Group S.A. | 8,589,064 | $12,884 | 0.55% |
| NEA Management Company, LLC | 4,764,440 | $7,146,660 | 0.55% |
| BVF INC/IL | 9,544,262 | $14,316,393 | 0.39% |
| Intellectus Partners, LLC | 61,975 | $92,963 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 27,500 | $41,250 | 0.03% |
| Sargent Investment Group, LLC | 58,000 | $87,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 93,785 | $141 | 0.01% |
| AXA S.A. | 1,625,698 | $2,438,547 | 0.01% |
| XTX Topco Ltd | 32,722 | $49,083 | 0.01% |